Exostemtech

Exostemtech is a South Korean biotechnology company focused on developing next-generation regenerative medicines using stem cell-derived exosomes. The company's core technology involves the isolation and large-scale production of high-purity exosomes that carry therapeutic proteins and genetic material to target cells. Their lead program, EST-P-EXO1, is a first-in-class exosome therapeutic for osteoarthritis that has entered clinical trials in South Korea. In addition to its pharmaceutical pipeline, Exostemtech develops exosome-based products for the aesthetics and cosmetics industry, targeting skin rejuvenation and hair loss. The company aims to address unmet medical needs in chronic inflammatory and degenerative diseases through its versatile exosome platform.